Literature DB >> 15983902

Tumor necrosis factor inhibition and invasive fungal infections.

Scott G Filler1, Michael R Yeaman, Donald C Sheppard.   

Abstract

Candida albicans and Aspergillus fumigatus occur ubiquitously in nature; C. albicans is part of the natural flora of most healthy individuals, and A. fumigatus is commonly found in soil, plant debris, and indoor air. Neither fungus poses a threat to healthy individuals, but each can cause fatal infections in immunocompromised patients. The use of tumor necrosis factor (TNF) antagonists for the treatment of rheumatoid arthritis and other autoimmune diseases has been associated with an increased incidence of opportunistic infections, including infections with both of these fungi. Because the use of TNF antagonists is expected to increase in the future, understanding the role that TNF plays and the effect of its antagonism on host defense against infections with these fungi is critical for reducing the associated morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15983902     DOI: 10.1086/430000

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  31 in total

Review 1.  Epithelial cells and innate antifungal defense.

Authors:  G Weindl; J Wagener; M Schaller
Journal:  J Dent Res       Date:  2010-04-15       Impact factor: 6.116

Review 2.  Biological therapy and dentistry: a review paper.

Authors:  Lida Radfar; Roshanak E Ahmadabadi; Farah Masood; R Hal Scofield
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-07-31

3.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; P Emery; E C Keystone; M H Schiff; P L C M van Riel; M E Weinblatt; M H Weisman
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 4.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 5.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Authors:  Fang Shen; Sarah L Gaffen
Journal:  Cytokine       Date:  2008-01-04       Impact factor: 3.861

Review 6.  IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans.

Authors:  Heather R Conti; Sarah L Gaffen
Journal:  J Immunol       Date:  2015-08-01       Impact factor: 5.422

7.  The Transmembrane Adaptor Protein SCIMP Facilitates Sustained Dectin-1 Signaling in Dendritic Cells.

Authors:  Jarmila Kralova; Matej Fabisik; Jana Pokorna; Tereza Skopcova; Bernard Malissen; Tomas Brdicka
Journal:  J Biol Chem       Date:  2016-06-10       Impact factor: 5.157

8.  Early Interaction of Alternaria infectoria Conidia with Macrophages.

Authors:  M C Almeida; D Antunes; B M A Silva; L Rodrigues; M Mota; O Borges; C Fernandes; T Gonçalves
Journal:  Mycopathologia       Date:  2019-06-11       Impact factor: 2.574

9.  Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling.

Authors:  Günther Weindl; Julian R Naglik; Susanne Kaesler; Tilo Biedermann; Bernhard Hube; Hans Christian Korting; Martin Schaller
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Extreme evolutionary disparities seen in positive selection across seven complex diseases.

Authors:  Erik Corona; Joel T Dudley; Atul J Butte
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.